abiraterone has been researched along with sphingosine in 1 studies
Studies (abiraterone) | Trials (abiraterone) | Recent Studies (post-2010) (abiraterone) | Studies (sphingosine) | Trials (sphingosine) | Recent Studies (post-2010) (sphingosine) |
---|---|---|---|---|---|
942 | 97 | 854 | 8,325 | 117 | 3,459 |
Protein | Taxonomy | abiraterone (IC50) | sphingosine (IC50) |
---|---|---|---|
ubiquitin-conjugating enzyme E2 N | Homo sapiens (human) | 6.3125 | |
cAMP-dependent protein kinase catalytic subunit alpha | Rattus norvegicus (Norway rat) | 0.098 | |
Sphingosine kinase 2 | Homo sapiens (human) | 1.56 | |
Sphingosine kinase 1 | Homo sapiens (human) | 3.86 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Azad, AA; Bonnitcha, P; Briscoe, K; Butler, LM; Crumbaker, M; Davis, ID; Du, P; Fettke, H; Fitzpatrick, M; Horvath, LG; Huynh, K; Jia, S; Joshua, AM; Kwan, EM; Lin, HM; Mahon, KL; Mak, B; Marx, G; Meikle, PJ; Meikle, TG; Mellett, NA; Scheinberg, T; Stockler, MR; Stricker, PD; Sullivan, DR; Tran, B; Yeung, N; Yu, J; Zhang, A | 1 |
1 other study(ies) available for abiraterone and sphingosine
Article | Year |
---|---|
Overcoming enzalutamide resistance in metastatic prostate cancer by targeting sphingosine kinase.
Topics: Aged; Aged, 80 and over; Androstenes; Benzamides; Biomarkers, Tumor; Cell Line, Tumor; Ceramides; Circulating Tumor DNA; Drug Resistance, Neoplasm; Humans; Lysophospholipids; Male; Nitriles; Phenylthiohydantoin; Phosphotransferases (Alcohol Group Acceptor); Progression-Free Survival; Prostatic Neoplasms, Castration-Resistant; Receptors, Androgen; Signal Transduction; Sphingosine | 2021 |